SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is trending after announcing strong Q4 earnings, reaffirming robust FY26 revenue guidance, and securing new defense contracts for missile propulsion and an Air Force project advancing multi-domain swarming autonomy; this news is sparking community debate on its long-term growth potential amidst high short interest and market volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical ($DRTS) is trending as the community celebrates its groundbreaking Japan PMDA approval for Alpha DaRT, a significant validation that is fueling expectations for substantial upside with further clinical catalysts and increased institutional interest.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending after delivering a strong earnings report driven by accelerated AI chip sales and an optimistic future outlook, including significant AI revenue targets and a new share repurchase program. The community is largely bullish on its growth and new OpenAI partnership, though some express caution about potential post-earnings volatility.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending following reports of early talks with OpenAI for ad sales and a massive $148 million insider share purchase by its CEO, sparking community excitement about a potential short squeeze and a major turnaround for the recently oversold stock.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is a top trending stock as its Q4 earnings report highlights a net loss due to heavy investments and competitive pressures, yet also showcases resilient core retail, substantial cash, and ongoing shareholder returns through dividends and buybacks, fueling community debate about its undervalued status and strategic path in the challenging Chinese e-commerce sector.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is trending as its recent earnings report sparks intense debate regarding reported EPS figures and growth trajectory. The community is split between those highlighting strong revenue, record customer asset growth, and an undervalued position compared to peers, versus concerns over high operating expenses and dilution from the Yorkville deal.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia (LQDA) is gaining significant investor attention following impressive preliminary Yutrepia sales and early profitability, surpassing market expectations in the pulmonary hypertension space. The community is now keenly focused on an imminent court ruling regarding patent litigation against United Therapeutics, anticipating a favorable decision that many believe could further drive the stock's growth and acquisition potential.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending as its Q4 earnings report highlighted early, albeit modest, revenue momentum and rapid payer coverage for its newly launched Komzifti, a perceived best-in-class menin inhibitor. The community is actively debating if the initial sales and strong cash runway into 2027 outweigh the reported top-line financial misses, contrasting its market entry against competitors in the oncology sector.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

VEEV is trending following strong quarterly earnings and optimistic forward guidance that surpassed analyst estimates, showcasing its pricing power and defensibility as a vertical SaaS leader in the highly regulated life sciences sector. The community is actively discussing its robust growth, significant trading volume, and the potential for its Vault CRM and AI initiatives, while also noting ongoing competition with Salesforce.

BJ's Wholesale Club Holdings, Inc. engages in the operation of membership warehouse clubs. Its product categories include grocery, household and pet, television and electronics, furniture, computer and tablets, patio and outdoor living, lawn and garden, baby and kids, toys, home, health and beauty, appliances, and jewelry. The company was founded in 1984 and is headquartered in Marlborough, MA.

BJ`s Wholesale Club Holdings Inc

BJ's Wholesale Club Holdings Inc

BJ's Wholesale Club is trending following its Q4 '26 earnings report, which highlighted increased EPS and revenue alongside positive fiscal 2026 guidance. The community is actively discussing its valuation relative to peers like Costco and whether recent analyst downgrades are warranted, contrasting with a historical tendency for the stock to dip post-earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enlivex Therapeutics (NASDAQ:ENLV) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised shares of Enlivex Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Wednesday

Enlivex Therapeutics (NASDAQ:ENLV) will be releasing earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Enlivex Therapeutics (NASDAQ:ENLV) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Enlivex Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update

Enlivex Therapeutics Ltd. (NASDAQ:ENLV - Get Free Report) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 526,156 shares...

Short Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Drops By 66.6%

Enlivex Therapeutics Ltd. (NASDAQ:ENLV - Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 201,697 shares, a...

Enlivex Therapeutics (NASDAQ:ENLV) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded Enlivex Therapeutics from a "strong sell" rating to a "hold" rating in a report on Saturday...

Enlivex Therapeutics Ltd. (NASDAQ:ENLV - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 603,238 shares...

Greenberg Traurig Advises Enlivex in $212M Private Placement

Greenberg Traurig Advises Enlivex in $212M Private Placement Greenberg Traurig Advises Enlivex in $212M Private Placement PR Newswire MIAMI, Dec. 4, 2025 Enlivex Becomes World's First Publicly Traded...

Small Cap Stocks To Add to Your Watchlist - November 24th

Direxion Daily GOOGL Bull 2X Shares, Spring Valley Acquisition, Direxion Daily TSLA Bear 1X Shares, Surmodics, and Enlivex Therapeutics are the five Small Cap stocks to watch today, according to...

Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors PR Newswire NESS ZIONA, Israel, Nov...

Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

ENLV
Enlivex Therapeutics Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ENLV News

ENLVEnlivex Therapeutics Ltd